Patients with dementia are particularly vulnerable during the COVID-19 pandemic. The initial response to COVID-19 promoted behavioral changes in both society and healthcare, while a long-term solution is sought by prioritizing societal values. In addition, there has been disruption to clinical care and clinical research. This pandemic might have significantly changed the care for our patients with dementia toward increased acceptance of telemedicine by the patients and providers, and its utilization in both clinical care and research.
All Keywords
【저자키워드】 COVID-19, coronavirus, clinical trial, pandemic, Health care, telehealth, Alzheimer’s disease, telemedicine., Dementia, access, Caregivers,
【저자키워드】 COVID-19, coronavirus, clinical trial, pandemic, Health care, telehealth, Alzheimer’s disease, telemedicine., Dementia, access, Caregivers,